About 500 reports

  • GLOBAL BREAST CANCER MABS MARKET: IMPACT ASSESSMENT OF KEY TRENDS
  • KEY MARKET HIGHLIGHTS
  • Pathology
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group

Thus, outsourcing the manufacturing of biosimilar products to developing nations would enable market vendors to achieve the quickest and most cost-effective method of getting new products to the market.

  • Cancer
  • Chemotherapy
  • Oncology
  • Pathology
  • Therapy
  • STRATEGIC ALLIANCES AND M&A

As vendors are facing the problem of a decline in venture capital investment, they are increasingly following the strategy of outsourcing.

  • Diabetes Care
  • Pathology
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Biosimilars market in India 2015-2020 ($ millions)

Thus, outsourcing the manufacture of biosimilar products to developing nations would enable market vendors to achieve the quickest and most cost-effective method of getting a new product to market.

  • Pathology
  • Biocon Limited
  • Hospira, Inc.
  • Sandoz Inc.
  • Teva Pharmaceuticals Ltd.

Outsourcing from hospitals to reference laboratories Value-based outsourcing is one of the major focuses of the market, where the laboratory tests are outsourced from hospitals to clinical reference laboratories.

  • Pathology
  • World
  • Forecast
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • However, strong pipeline and increased outsourcing of drug development will offset this negative impact.
  • ADCS MARKET IN JAPAN 2015
  • Pathology
  • Hoffmann-La Roche Inc.
  • ImmunoGen, Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Market trends
  • Introduction

For the global drug makers, the CROs based in India, China, Russia, and Eastern Europe remain the favorite outsourcing destinations.

  • Pathology
  • Forecast
  • AbbVie Inc.
  • Allergan plc
  • Pfizer Inc.

Contract research organizations (CROs) are increasing in the market due to increased outsourcing of product research.

  • Pathology
  • World
  • Abcam plc
  • Alere Inc.
  • Quidel Corporation
  • IMPACT OF DRIVERS AND CHALLENGES
  • Introduction

FAVORABLE REIMBURSEMENT SCENARIO Countries US GERMANY Reimbursement body Average reimbursement for VAD The German Health Insurance System Pharmaceutical and Medical devices Agency $##, ## for first- and second-generation VADs $##, ## Medicare $##, ## OUTSOURCING RESEARCH STUDIES ON VADS

  • Hospital
  • Pathology
  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Jude Medical, Inc.

Increasing government initiatives, the low number of pathologists, growing outsourcing of pathology services, and increasing demand for quality diagnostics are the major factors driving the demand for digital pathology in these markets.

  • Pathology
  • Europe
  • World
  • Market Size
  • Firm/Total Company
  • European Country Population Aged 65 and Above, 2011-2015 (% of Total)
  • Global Antibody Drug Conjugates Market-Strategic Recommendations

OUTSOURCING OF ADC MANUFACTURING TO CMOS Global Antibody Drug Conjugates Market-Strategic Recommendations MANUFACTURING OF ADC IS QUITE COMPLEX AND REQUIRES SPECIAL EQUIPMENT.

  • Pathology
  • World
  • Market Size
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.

R& D outsourcing becomes essential, as the device companies seek to accelerate development cycles, cut costs, and increase the market share as a part of business strategy.

  • Diabetes
  • Diabetes Care
  • Drug Delivery
  • Injectable Delivery
  • Pathology

Digirad Corporation entered into an outsourcing agreement with Spectrum Assembly, Inc.

  • Pathology
  • Market Size
  • Digirad Corporation
  • GE Healthcare Limited
  • Toshiba Corporation

Furthermore, biopharmaceutical and pharmaceutical companies are increasingly focusing on drug discovery outsourcing.

  • Diabetes Care
  • Pathology
  • Market Size
  • Alere Inc.
  • Sysmex Corporation
  • US INFECTIOUS DISEASE POCT SALES FORECAST ($M), 2013-2022
  • AND FIGURE 18 PRESENT THE US SALES FORECAST FOR INFECTIOUS DISEASE POCT FROM 2013- 2022.

AS IT STANDS, THE MAJORITY OF LARGE TERTIARY HOSPITALS IN CHINA INCLUDE IN-HOUSE IVD LABS EQUIPPED WITH HIGH-VOLUME AUTOMATED TESTING CAPABILITIES, AND THE OUTSOURCING TO REFERENCE LABS IS LIMITED, EXCEPT FOR NICHE AND LOW-DEMAND DIAGNOSTIC TESTS.

  • Diabetes Care
  • Pathology
  • Forecast
  • Alere Inc.
  • Beckman Coulter, Inc.

Economy: The manufacture and development of a vaccine molecule requires an investment of about $## million, which is ##% less compared to developed countries, giving India and China an advantage as an attractive place for investment and manufacturing outsourcing.

  • Pathology
  • Market Size
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Outsourcing), among others He is a seasoned professional with expertise in data mining, data analytics, market estimation, competitive intelligence mapping, and industry/ company assessment, among others.

  • Pathology
  • Hologic, Inc.
  • InBody Co., Ltd.
  • Omron Corporation
  • Tanita Corporation

Prior to joining MarketsandMarkets, he served leading pharmaceutical client of WNS Global Services (A leading knowledge processing outsourcing company) for close to one year.

  • Pathology
  • Cutera, Inc.
  • Lumenis Ltd.
  • PhotoMedex, Inc.
  • Valeant Pharmaceuticals International, Inc.

Cost savings and a lack of regulations have been one of the most important drivers of outsourcing of preclinical activities to China.

  • Pathology
  • Forecast
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.

Therefore, these laboratories act as outsourcing platforms for hospitals with budgetary constraints, poor infrastructure, and lack of skilled professionals.

  • Diabetes Care
  • Pathology
  • World
  • Forecast
  • Alere Inc.
  • HUMANIZEDMOUSEMODEL MARKET SIZEFOR CONTRACT RESEARCHORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)

Cost savings and a lack of regulations are among the most important drivers boosting the outsourcing of preclinical activities to China.

  • Pathology
  • World
  • genOway SA
  • Horizon Discovery
  • Taconic Biosciences, Inc.

Focusing on innovation through the internal research and development, selected acquisitions, and in-licensing; Focusing on productivity through measures such as leveraging industry overcapacity and outsourcing commodity services; Focusing on critical skills and capabilities needed to bring

  • Diabetes Care
  • Pathology
  • World
  • Alcon, Inc.
  • Carl Zeiss AG

Challenges Antigenic drift and Antigenic shift of Influenza Viruses High Research and Development Cost Competitive Landscape Falvogen, Gilead Science and Bio Cryst Strategic Recommendations Focus on APAC region Multiple licensing and collaboration Outsourcing of ADC manufacturing to CMOs Pr

  • Pathology
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.

Outsourcing Patient Monitoring and Mobile Monitoring Converged Wireless Networks System Compatibility ##: Global Market Size and Forecast Overview Total Global Market Size and Forecast Global Equipment and Device Markets by Product Segment Blood Management and Function Monitors Cardia

  • Pathology
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast

outsourcing activity of Big Pharma" s to the Chinese market.

  • Analgesic
  • Pathology
  • Therapy
  • World
  • AstraZeneca PLC

Vendors are increasingly outsourcing parts of their manufacturing process to Asian countries such as China and India because of the low cost of production in these countries.

  • Pathology
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Stryker Corporation

Outsourcing of laboratory services by hospitals is one of the key trends that contributes to market growth.

  • Hospital
  • Immunochemistry Test
  • In Vitro Diagnostics
  • Laboratory
  • Pathology

AS IT STANDS, THE MAJORITY OF LARGE TERTIARY HOSPITALS IN CHINA INCLUDE IN-HOUSE IVD LABS EQUIPPED WITH HIGH-VOLUME, AUTOMATED TESTING CAPABILITIES, AND THE OUTSOURCING TO REFERENCE LABS IS LIMITED, EXCEPT FOR NICHE AND LOW-DEMAND DIAGNOSTIC TESTS.

  • Diabetes Care
  • Pathology
  • Alere Inc.
  • Beckman Coulter, Inc.
  • bioMerieux S.A.

THEY MAINTAIN A LONG-STANDING SUPPLYING RELATIONSHIP WITH DIRECT SALES REPRESENTATIVES AND THIRD PARTY DISTRIBUTORS FOR OUTSOURCING THEIR PRODUCTS.

  • Hospital
  • Medical Device
  • Pathology
  • Urology
  • Urology Device
  • Market challenges

As a result, many facilities are outsourcing these procedures, which can compromise specimen integrity, lead to delays in the diagnosis of diseases, and impact patient outcomes.

  • Pathology
  • United States
  • Alere Inc.
  • Cepheid
  • DiaSorin S.p.A.